AlzeCure selects drug candidate and enters next phase of development against severe pain
AlzeCure Pharma AB, a pharmaceutical company that develops a broad portfolio of small molecule candidate drugs for diseases affecting the...
Read More
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse
AlzeCure Pharma AB, a pharmaceutical company that develops a broad portfolio of small molecule candidate drugs for diseases affecting the...
Read MoreA new study ‒ that has examined all cardiac arrests occurring during or soon after surgery in more than 300...
Read MoreJames Watts, Consultant in Anaesthesia and Critical Care Medicine, East Lancashire NHS Trust, looks into working conditions and pay in...
Read MorePatients from the German town of Attendorn are being prescribed vital data monitoring as part of a study into how...
Read MorePeople with chronic pain are often dependent on drugs from the class of opioids with sometimes considerable side effects. Accordingly,...
Read MoreSimulated high altitude could help older patients at risk of health complications related to surgery, a new study has found....
Read MoreA novel 3D printed device that could replace the need for drug and chemical safety testing on animals has received...
Read MoreResponse to letter to the editor: Coiling of guidewire – Out of date Vascath Set Thank you very much...
Read MoreJournal of Anaesthesia Practice is a leading online title in the field of anaesthesia
Journal of Anaesthesia Practice is a unique online vehicle for getting an anaesthetic product or service in front of the people who really matter. The vast majority of the readership are consultant anaesthetists.